SIROLIMUS | A208691 | GLENMARK PHARMACEUTICALS LTD
Highest NADAC/Unit
$2.64
per ea
Lowest NADAC/Unit
$0.8350
per ea
Brand NDCs
0
Generic NDCs
6
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 68462068401SIROLIMUS 2 MG TABLET | $2.64 | EA | Generic | — | 2026-08-19 |
| 16714018901SIROLIMUS 2 MG TABLET | $2.64 | EA | Generic | — | 2026-08-19 |
| 68462068201SIROLIMUS 0.5 MG TABLET | $0.9386 | EA | Generic | — | 2026-08-19 |
| 16714018701SIROLIMUS 0.5 MG TABLET | $0.9386 | EA | Generic | — | 2026-08-19 |
| 68462068301SIROLIMUS 1 MG TABLET | $0.8350 | EA | Generic | — | 2026-08-19 |
| 16714018801SIROLIMUS 1 MG TABLET | $0.8350 | EA | Generic | — | 2026-08-19 |
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.
No patent or exclusivity listings for this strength.